Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 2399 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Evotec–Berenberg: investor conference, 201712 supply service Evotec presents at Berenberg European Conference in Surrey 2017-12-06
Evotec–Deutsche Börse: investor conference, 201711 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2017 2017-11-27
Evotec–Volks- und Raiffensenbanken (DE): investor conference, 201711 supply service Evotec attends DZ Bank Equity Conference 2017 in Ffm 2017-11-22
Evotec–Leucadia: investor conference, 201711 supply service Evotec AG presents at Jefferies 2017 Global Healthcare Conference London 2017-11-15
Curetis–Ladenburg Thalmann: investor conference, 201709 supply service Curetis presents at Ladenburg Thalmann 2017 Healthcare Conference in NY 2017-09-26
Curetis–Cantor Fitzgerald: investor conference, 201709 supply service Curetis presents at Cantor Fitzegerald Global Healthcare Conference in NY 2017-09-25
Evotec–Baader Bank: investor conference, 201709 supply service Evotec attends Baader Investment Conference 2017 in Munich 2017-09-20
Evotec–Berenberg: investor conference, 201709 supply service Evotec presents at 6th German Corporate Conference in Munich 2017-09-18
Evotec–Goldman Sachs: investor conference, 201709 supply service Evotec presents at 7th Annual Biotech Symposium in London 2017-09-18
Curetis–Rodman & Renshaw: investor conference, 201709 supply service Curetis presents at Rodman & Renshaw Global Investment Conference in NY 2017-09-10
DiaSorin–Siemens: ELISA immunoassays, 201707– acquisition up to €47.5m of Siemens ELISA Dx portfolio/assets without employees + mftg capacity 2017-07-25
Boehringer–Philogen: drug discovery services, 201707– collab €na discovery + optimisation of small molecule drugs using ESAC technology 2017-07-20
SpinDiag–SEVERAL: investment, 201707 seed financing round €1.6m from three private investors 2017-07-20
Shire–Novimmune: therapeutic antibodies, 201707– license ww excl €na to bispecific antibody for hemophilia A 2017-07-18
TomTec Imaging–Philips: investment, 201707– acquisition €na of TomTec Imaging Systems GmbH by Philips ANNOUNCED 2017-07-18
ABF–Genedata: bioinformatics, 201707– supply expansion use of Genedata Selector by AB Enzymes for decision support 2017-07-11
Blueprint Genetics–Creathor Venture: investment, 201707 financing round totalling up to €14m incl new + co-lead investor Creathor Venture 2017-07-11
Blueprint Genetics–Inventure: investment, 201707 financing round totalling up to €14m incl existing + co-investor Inventure 2017-07-11
Blueprint Genetics–MedTech Innovation Partners: investment, 201707 financing round totalling up to €14m incl new + co-lead investor MTIP 2017-07-11
Blueprint Genetics–Pontos Group: investment, 201707 financing round totalling up to €14m incl existing + co-investor Pontos Group 2017-07-11
Blueprint Genetics–SEVERAL: investment, 201707 financing round up to €14m led by Creathor Venture + MTIP + incl Inventure + Pontos Group 2017-07-11
CRISPR Therapeutics–Piper Jaffray: investor conference, 201707 supply service CRISPR Therapeutics presents at Piper Jaffray GenomeRx Symposium in NYC 2017-07-11
Nestlé–Enterome: diagnostics, 201707– collab establishm of 50/50 jv MDP to develop microbiome-based diagnostics except for immuno-oncology 2017-07-11
CRISPR Therapeutics–Neon Therapeutics: T cell therapy, 201707– collab combi of proprietary technologies to develop T cell therapies 2017-07-10
Endress+Hauser–GUS Group: investment, 201707 acquisition of AJ Blomesystem GmbH by GUS Group 2017-07-01
Evotec–Hamburg (govt): grant, 201707– 201906 RnD grant from IFB Hamburg to develop AB-based cancer therapies with UKE 2017-07-01
mySugr–Roche: investment, 201706 acquisition of remaining shares by Roche 2017-06-30
Evotec–Censo Biotechnologies: stem cell technology, 201706–201905 strategic collab €na with Censo supplying iPS cell lines to Evotec 2017-06-28
Indi Molecular–Merck (DE): investment, 201706 financing round Series A totalling $11.5m led by Merck Ventures + Legend Capital 2017-06-28
Indi Molecular–SEVERAL: investment, 201706 financing round Series A $11.5m led by Merck Ventures + Legend Capital 2017-06-28
BioGeneration Ventures–EU (govt): investment, 201706 investment by EIF + other new investors bringing total capital of BGV III to €66m 2017-06-27
BioGeneration Ventures–SEVERAL: investment, 201706 investm by EIF + other new investors bringing total capital of BGV III to €66m with max target €75m 2017-06-27
CatalYm–BioGeneration Ventures: investment, 201706 CatalYm GmbH is existent investment of BGV III fund 2017-06-27
Sensovation–Miltenyi Biotec: investment, 201706 acquisition by Milteny from HeidelbergCapital + KfW/tbg 2017-06-27
Takeda–JSR Corp: cell line development, 201706– commercial license to use Selexis’ SUREtechnology for developm of fusion proteins 2017-06-27
Ottobock–EQT: investment, 201706 EQT VII fund to acquire 20% stake from Otto Bock HealthCare GmbH valuing Ottobock at €3.15b 2017-06-24
DiaSorin–Qiagen: in vitro diagnostics, 201706– collab to adopt select Qiagen assays for use on Liaison platform 2017-06-22
AlsaChim–Shimadzu: investment, 201706 acquisition €na of 100% of AlsaChim by Shimadzu Europe 2017-06-21
Evotec–Deutsche Bank: investor conference, 201706 supply service Evotec presents at dbAccess Berlin Conference 2017-06-21
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
CRISPR Therapeutics–JMP Securities: investor conference, 201706 supply service CRISPR Tx presents at JMP Securities 2017 Life Sciences Conference NY 2017-06-20
Debiopharm–Almac: kinase inhibitor, 201706– license ww excl to Wee-1 kinase inhibitor programme of Almac Discovery 2017-06-20
Facio Therapies–Evotec: investment, 201706c financing round totalling €4.8m incl strategic investment by Evotec 2017-06-20
Facio Therapies–SEVERAL: investment, 201706c financing round €4.8m incl Evotec + members of intl FSHD community 2017-06-20
Idorsia–JnJ: investment, 201706 acquisition of 9.9% share in Idorsia by Cilag Holding AG via conversion of CFH135.4m convertable loan 2017-06-20
Euroimmun–PerkinElmer: investment, 201706– acquisition $1.3b in cash ANNOUNCED 2017-06-19
Probiodrug–BIO (US): partnering conference, 201706 supply service Probiodrug Presents at BIO International Convention 2017-06-19
Takeda–Wilex: antibody-drug conjugates, 201706– collab developm of ADCs using ATACs for up to 3 targets Heidelberg Pharma + Millennium 2017-06-19
TxCell–Miltenyi Biotec: lentiviral vector, 201706– supply of lentiviral vector for TxCell’s CAR-Tregs targeting transplant rejection by Lentigen 2017-06-19
Broughton Laboratories–Thermo Fisher: LC system, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
Broughton Laboratories–Thermo Fisher: mass spectrometer, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
GreenBone–Helsinn: investment, 201706 2nd financing round incl €2m from lead investor Helsinn Investment Fund 2017-06-16
GreenBone–SEVERAL: investment, 201706 2nd financing round incl lead investor Helsinn Investment Fund 2017-06-16
Idorsia–OTHER: investment, 201706 listing at SIX Swiss Exchang as part of acquisition of Actelion by JnJ and spin-off of Idorsia 2017-06-16
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
TissUse–Minapharm: organ-on-a-chip technology, 201706– license for HuALN platform for Multi-Organ-Chip applications from ProBioGen 2017-06-15
Bayer–China (govt): wheat breeding, 201706– collab 2y with SIBS + SIPPE to improve wheat yields via improved photosynthetic efficiency 2017-06-14
Bruker Corp–Goldman Sachs: investor conference, 201706 supply service Bruker presents at 38th Annual Global Healthcare Conference 2017-06-14
MorphoSys–Deutsche Bank: investor conference, 201706 supply service MorphoSys presents at dbAccess Berlin Conference 2017-06-14
MorphoSys–Goldman Sachs: investor conference, 201706 supply service MorphoSys presents at 38th Annual Global Healthcare Conference 2017-06-14
Selexis–JSR Corp: investment, 201706– acquisition €na of Selexis SA by JSR Corp ANNOUNCED 2017-06-14
Bruker Corp–William Blair: investor conference, 201706 supply service Bruker presents at William Blair Annual Growth Stock Conference in Chicago 2017-06-13
Centogene–Careventures: investment, 201706 financing round Series A totalling €25m incl co-investor Careventures 2017-06-13
Centogene–Crédit Mutuel-CIC: investment, 201706 financing round Series A totalling €25m incl co-investor CIC Capital 2017-06-13
Centogene–DPE Deutsche Private Equity: investment, 201706 financing round Series A totalling €25m incl co-investor DPE 2017-06-13
Centogene–SEVERAL: investment, 201706 financing round Series A €25m led by TVM Capital + incl DPE + Careventures + CIC Capital 2017-06-13
Centogene–TVM: investment, 201706 financing round Series A totalling €25m incl lead investor TVM Capital Life Science 2017-06-13
CureVac–TiberendStrategic Advisors: public relations, 201706 service existent by Tiberend 2017-06-13
4SC–SEVERAL: investment, 201706–201707 cash capital increase €41m with 11.68m new shares at €3.5/share 2017-06-12
TeneoBio–Selexis: cell line development, 201706– supply service access to SUREtechnology platform to develop cell expression of UniAbs 2017-06-12
Bruker Corp–Leucadia: investor conference, 201706 supply service Bruker presents at Jefferies Healthcare Conference in New York 2017-06-08
Lilly–Nordic Bioscience: antidiabetic, 201706– strategic collab $55m upfront + milestones + royalties ww rights to develop DACRAs from KeyBioscience 2017-06-08
Grünenthal–AstraZeneca: zolmitriptan, 201706 acquisition ww rights excl JP to Zomig $200m upfront + $102m milestones by Grünenthal 2017-06-07
Omeicos Therapeutics–Germany (govt): grant, 201706– additional BMBF research grant €1.7m 2017-06-07
CRISPR Therapeutics–Orgenesis: CAR-T cell therapies, 201706– supply CDMO services for allogenic CAR-T therapy CTX101 by MaSTherCell SA 2017-06-06
Probiodrug–Leucadia: investor conference, 201706 supply service Probiodrug presents at Jefferies Healthcare Conference in New York 2017-06-06
Thermo Fisher–Biocrates: AbsoluteIDQ Kits, 201706– collab co-marketing of new AbsoluteIDQ p400 HR Kit with Q Exactive HRAM MS systems 2017-06-05
Thermo Fisher–Biognosys: mass spectrometry s/w, 201706– collab co-marketing of Spectronaut Pulsar s/w with Orbitrap mass spectrometers 2017-06-05
Univ Maastricht–Bruker Corp: mass spectrometry software, 201706 supply existent use of SCilS Lab s/w by M4I 2017-06-05
Merck (DE)–F-Star: antibody cancer drug, 201706– strategic collab to develop 5 bispecific antibodies incl lead asset FS118 2017-06-04
BMS–Qiagen: molecular companion diagnostics, 201706– collab using NGS to develop gene expression profiles for cancer immunotherapies 2017-06-03
Qiagen–Johns Hopkins Univ: cancer biomarker, 201705– license ww to genetic biomarkers for use in I-O patient selection 2017-06-03
GATC Biotech–Eurofins: investment, 201706–201707 acquisition €na of GATC Biotech AG by Eurofins Scientific SE 2017-06-02
Bicycle Therapeutics–SEVERAL: investment, 201706 financing round Series B £40m led by new investor Vertex Ventures HC 2017-06-01
Indivumed–LADR/Intermed: investment, 201706 investment by Intermed as part of strategic alliance 2017-06-01
Inthera Bioscience–SEVERAL: investment, 201705 financing round Series A CHF10.5m Merck Ventures + Aglaia BioMedical + Novo Seeds + private investor 2017-05-31
Strekin–SEVERAL: investment, 201705 financing round Series C CHF10m from private investors 2017-05-31
High-Tech Gründerfonds–SEVERAL: investment, 201705 first closing €245m of High-Tech Gründerfonds III (HTGF III) 2017-05-30
Taconic–ERS Genomics: CRISPR technology, 201705– license ww non-excl for CRISPR-Cas9 technology to generate murine models 2017-05-30
Wise (IT)–SEVERAL: investment, 201705 financing round Series B €6.5m led by Prinicpia SGR + incl Atlante Ventures + HTGF + F3F + Antares 2017-05-25
Debiopharm–ImmunoGen: antibody-drug conjugate, 201704 acquisition $25m upfront + $30m milestones of anti-CD37 ADC IMGN529 by Debiopharm 2017-05-24
MorphoSys–Berenberg: investor conference, 201705 supply service MorphoSys presents at Berenberg European Conference USA in Tarrytown 2017-05-24
Sartorius–SEVERAL: credit, 201705– note loan €350m with maturity terms of 5, 7 + 10 years arranged by Commerzbank + LBBW 2017-05-24
CRISPR Therapeutics–UBS: investor conference, 201705 supply service CRISPR Tx presents at UBS Global Healthcare Conference NY 2017-05-23
Helsinn–UBS: investor conference, 201705 supply service Helsinn Therapeutics (U.S.) Inc presents at UBS Global Healthcare Conference NY 2017-05-23
OSE Immunotherapeutics–Selexis: cell line development, 201705– commercial license for access to RCBs from SUREtechnology platform 2017-05-23
Signatope–High-Tech Gründerfonds: investment, 201705 investment €600k by HTGF 2017-05-23
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px